BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 1092110)

  • 1. [Antibodies to type antigens of group A streptococcal cell walls in erysipelas patients].
    Cherkasov VL; Chistenkov NA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):68-73. PubMed ID: 1092110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of antibodies against ribosomes and various cell wall components and detection of circulating antigens of group A Streptococcus in patients with erysipelas].
    Shikhman AR; Anokhina GI; Cherkasov VL; Nikolaeva LV; Savel'ev EP
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Dec; (12):91-5. PubMed ID: 3548176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of chronic recurrent erysipelas with streptococcal vaccine].
    Haustein UF; Biella U; Tausch I; Knöll H
    Hautarzt; 1989 Apr; 40(4):215-21. PubMed ID: 2659550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The level of IgM, IgG and IgA antibodies and total antibodies to the low-molecular, cell-wall protein of Streptococcus group A without type specificity in the serum of patients with a streptococcal infection].
    Molchanova TO; Shikhman AR; Briko NI
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Nov; (11):21-6. PubMed ID: 2097845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Free and bound antigen of Streptococcus group A L forms and the circulating immune complex level of erysipelas patients].
    Gorina LG; Kagan GIa; Gavrilova GA; Goncharova SA; Cherkasov VL
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):106-9. PubMed ID: 6195846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibodies to group A streptococcal polysaccharides in erysipelas].
    Borodiiuk NA; Cherkasov VL; Rassokhina II
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jan; (1):52-6. PubMed ID: 804779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibodies to non-type-specific group A streptococcal cell wall antigens in human sera].
    Borodiiuk NA; Bukhova VP; Liampert IM; Novikov FE; Cherkasov VL
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):79-83. PubMed ID: 6778036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of immunoenzyme analysis for evaluating the specificity of the antibody recognition of the antigenic determinants of Streptococcus group A].
    Shikhman AR
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):52-5. PubMed ID: 2413662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibodies reacting with epithelial cells of the thymus and skin in the sera of patients with rheumatism and erysipelas].
    Ryzhikova EA; Spirina GV; Cherkasov VL; Guseva NG; Liampert IM
    Vestn Akad Med Nauk SSSR; 1986; (7):45-9. PubMed ID: 3529692
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of detecting discrete antigens of group A Streptococcus and their antibodies in the blood of erysipelas patients].
    Cherkasov VL; Anokhina GI; Shikhman AR; Briko NI
    Klin Med (Mosk); 1995; 73(4):97-8. PubMed ID: 7474846
    [No Abstract]   [Full Text] [Related]  

  • 11. [Persistence of the L forms of hemolytic Streptococcus group A in patients with recurrent erysipelas].
    Gavrilova GA; Gorina LG; Goncharova SA; Cherkasov VL
    Vestn Akad Med Nauk SSSR; 1985; (3):13-7. PubMed ID: 3887793
    [No Abstract]   [Full Text] [Related]  

  • 12. [Haptoglobin type, serum concentration of haptoglobin and agglutinating titre against T4-antigen of Streptococcus pyogenes in erysipelas (author's transl)].
    Göring HD; Köhler W; Prokop O; Bergmann R
    Dermatol Monatsschr; 1981 Aug; 167(8):492-6. PubMed ID: 7049773
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of antibodies to Streptococcus group A polysaccharide by an immunodiffusion method in human sera in various pathological processes of streptococcal etiology].
    Borodiiuk NA; Liampert IM; Mikhaĭlova IN; Novikov FE; Cherkasov VL
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jun; (6):77-81. PubMed ID: 2412372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of indirect endolymphatic antibiotic therapy on clinical and immunological indicators in patients with erysipelas of the lower extremities].
    Levina LD; Ambalov IuM; Poliak AI; Aĭtkuluev NS; Kovalenko AP; Usatkin AV
    Antibiot Khimioter; 1992 Jun; 37(6):24-6. PubMed ID: 1417339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune reactions in diseases of streptococcal etiology].
    Bala MA; Korabel'nikov SV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (5):83-7. PubMed ID: 8067152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [T-cell responsiveness to specific group A streptococcus antigens in patients with recurrent erysipelas].
    Iudina IuV; Belaia OF; Pak SG; Erovichenkov AA
    Klin Lab Diagn; 2008 Apr; (4):14-8. PubMed ID: 18619201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of a sodium nucleinate and levamisole combination on the effectiveness of antibiotic therapy and bicillin prophylaxis of erysipelas recurrences].
    Frolov VM; Rychnev VE; Peresadin NA
    Antibiot Med Biotekhnol; 1987 May; 32(5):379-82. PubMed ID: 3606056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinico-immunological evaluation of the efficacy of indirect endolymphatic therapy with bicillin-3 in erysipelas patients].
    Ambalov IuM; Poliak AI; Levina LD; Aĭtkuluev NS; Kovalenko AP
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):114-5. PubMed ID: 8079530
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic antibiotics in erysipelas.
    Duvanel T; Mérot Y; Harms M; Saurat JH
    Lancet; 1985 Jun; 1(8442):1401. PubMed ID: 2861358
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bicillin prevention of relapsing erysipelas].
    Cherkasov VL; Samotolkin KN
    Sov Med; 1983; (11):96-8. PubMed ID: 6658591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.